Evergreen Lighting, a manufacturer of decorative, energy-efficient lighting products,
requires its buyers to pay for the cost of transportation from the manufacturing site to
their place of businesses. Evergreen Lighting uses FOB origin pricing.
a. True
b. False
Answer:
Novartis
Novartis, a Swiss drug maker, is planning to purchase a majority stake in Zhejiang
Tianyuan Bio-Pharmaceutical Company, a Chinese vaccine maker. Novartis has agreed
to pay $125 million for the company, which holds a 3 percent share of China’s $1
billion vaccines market. The market for vaccines is growing 20 percent or more in the
developing nations of Asia, Africa, and Australasia. In the past, vaccine use has been
limited to basic shots against diseases such as polio, tuberculosis, and measles, but as
the economies of these countries grow, government and private healthcare spending
focuses on preventing diseases such as hepatitis B, cholera and rotavirus, tetanus, and
others. Some critics are against the acquisition, claiming that prices will increase.
Novartis claims it is not interested in raising prices but rather in expanding Tianyuan’s
product offerings.
Refer to Novartis. One thing Novartis plans to do is increase sales to governments and
to the United Nations agencies since these are the typical buyers of vaccines to
distribute in poor countries. Thus, the company is willing to give up short-term profits
to increase market share for this company. In terms of the portfolio matrix, which basic
strategy will Novartis be implementing?
a. Holding
b. Harvesting
c. Divesting
d. Building
e. Diverting